الحمرة: وبائيات و دور العلاج باللينكومايسين

Authors

  • رولا بدور

Abstract

 

The aim of this research is to study statistically erysipelas cases and its precipitating factors and also to determine the possibility of considering intramuscular injection of lincomycin as an effective treatment of uncomplicated erysipelas instead of intravenous penicillin G.

60 cases of erysipelas were studied and evaluated. There was no significant relation to age, sex and site of infection. The most affected sites were lower limbs, then face, and upper limbs.

The most important risk factors were fungal intertrigo, vascular impairment and finally diabetes mellitus.

The response to lincomycin treatment was excellent in 71.71%, intermediate in 23.91% of patients, while there was no response in only 4.34% of cases.

يهدف البحث إلى إجراء دراسة إحصائية عن الحمرة والعوامل المؤهبة لحدوثها وكذلك جدوى اعتماد اللينكومايسين حقنا عضليا، علاجاً فعالاً بديلاً من العلاج الوريدي بالبنسلين في حالات الحمرة غير المختلطة. تمت دراسة وتقييم 60 حالة حمرة. لم نجد رابطا هاما بين الجنس والعمر أو مكان الإصابة.الموقع الأكثر إصابة كان الساق والأقل الوجه واليد. عامل الخطورة الأهم كان المذح الفطري يليه الاضطراب الوعائي ثم الرض الموضعي و بعده السكري. أما الاستجابة للعلاج باللينكومايسين فكانت ممتازة  لدى71.73% من الحالات و متوسطة لدى 23.91% فيما لم تحصل استجابة لدى 4.34% فقط.

Author Biography

رولا بدور

قسم الأمراض الجلدية-كلية الطب-جامعة تشرين-اللاذقية-سورية.

Downloads

Published

2013-03-24

How to Cite

1.
بدور ر. الحمرة: وبائيات و دور العلاج باللينكومايسين. Tuj-hlth [Internet]. 2013Mar.24 [cited 2024Apr.27];35(2). Available from: https://journal.tishreen.edu.sy/index.php/hlthscnc/article/view/195

Issue

Vol. 35 No. 2 (2013): العلوم الصحية

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

 Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series   .  The Readers have the right to send, print and subscribe to the initial version of the article, and the title of  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series  Publisher

journal uses a CC BY-NC-SA license which mean

You are free to:

  • Adapt — remix, transform, and build upon the material
  •  
  • The licensor cannot revoke these freedoms as long as you follow the license terms.

 

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.
  • ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Most read articles by the same author(s)